IMU being primarily a clinical R&D company would be having data coming out all over the place I expect .
The data could be beautiful , in the sense of how it is compiled .
Some data is crap data , some is OK data , some is beautiful data .
I guess a CEO is entitled to make encouraging statements about how he/she would perceive progress , and thats not uncommon in any company in any situation .
IMU
Price at posting:
3.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.